Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 55 (2-3) , 203-213
- https://doi.org/10.1016/s0165-0327(99)00073-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerationsHuman Psychopharmacology: Clinical and Experimental, 1998
- Do noradrenaline and serotonin differentially affect social motivation and behaviour?European Neuropsychopharmacology, 1997
- Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodesEuropean Neuropsychopharmacology, 1997
- Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitorEuropean Neuropsychopharmacology, 1997
- Antidepressants and the elderly: Double‐blind trials 1987‐1992International Journal of Geriatric Psychiatry, 1995
- Risks of Antidepressants in the Elderly: Tricyclic Antidepressants and Arrhythmia – Revising RisksGerontology, 1994
- An Overview of Paroxetine in the ElderlyGerontology, 1994
- Summarizing Laboratory Data with Different Reference Ranges in Multi-Center Clinical TrialsDrug Information Journal, 1992
- Depressive symptoms and signs that differentiate major and atypical depression from dysthymic disorder in elderly finnsInternational Journal of Geriatric Psychiatry, 1989
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960